Chemours Adds Glyclean™ D to Its World-Class Glycolic Acid Product Portfolio
The Chemours Company (NYSE: CC) has launched Glyclean™ D, a broad-spectrum disinfectant registered with the U.S. EPA to deactivate SARS-CoV-2 and other pathogens. This product, comprising 70% glycolic acid, is biodegradable and less corrosive than traditional disinfectants like bleach. The launch reflects Chemours' commitment to innovation, aiming to meet cleaning needs across North America, Europe, the Middle East, Asia, and Latin America. The company operates approximately 30 manufacturing sites and serves about 3,300 customers globally.
- Introduction of Glyclean™ D, an EPA-registered disinfectant effective against SARS-CoV-2.
- Glyclean™ D is biodegradable and environmentally friendly, appealing to eco-conscious consumers.
- Strengthening of product portfolio in response to increasing demand for effective disinfectants.
- None.
WILMINGTON, Del., Nov. 16, 2021 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announced the launch of Glyclean™ D —a proven broad spectrum disinfectant and cleaner, registered with the U.S. Environmental Protection Agency (EPA) to deactivate the SARS-CoV-2 virus, as well as other viruses and bacteria .
Formulated using a
"Even in times of unprecedented uncertainty, we continue to work closely with our customers to ensure they are able to deliver responsible and innovative products and solutions," said James Kanicky, Global Business Director, Chemical Solutions at Chemours. "We´re proud to add Glyclean™ D to our product portfolio as it demonstrates our commitment to bringing new solutions to market that are better, safer, more reliable, and more sustainable."
A nonflammable, VOC exempt, antimicrobial raw material based upon glycolic acid, Glyclean™ D has low corrosivity, making it effective for household and institutional cleaning applications, including removing soap scum and hard water deposits.
Glyclean™ D products are available to meet regional requirements in North America, Europe, the Middle East, Asia and Latin-American. For more information, please visit: GlycleanD.com.
About The Chemours Company
The Chemours Company (Chemours or the Company) (NYSE: CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a wide range of industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration, and air conditioning, transportation, semiconductor and consumer electronics, general industrial, mining and oil and gas. Our flagship products include prominent brands such as Ti-Pure™, Opteon™, Freon™, Nafion™, Krytox™, Teflon™, and Viton™. In 2019, Chemours was named to Newsweek's list of America's Most Responsible Companies. The company has approximately 6,500 employees and 30 manufacturing sites serving approximately 3,300 customers in approximately 120 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.
For more information, we invite you to visit chemours.com or follow us on Twitter @Chemours and LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, anticipated future operating and financial performance for our segments individually and our company as a whole, business plans, prospects, targets, goals and commitments, capital investments and projects and target capital expenditures, plans for dividends or share repurchases, sufficiency or longevity of intellectual property protection, cost reductions or savings targets, plans to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. In addition, the current COVID-19 pandemic has significantly impacted the national and global economy and commodity and financial markets, which has had and we expect will continue to have a negative impact on our financial results. The full extent and impact of the pandemic is unknown and to date has included extreme volatility in financial and commodity markets, a significant slowdown in economic activity, and increased predictions of a global recession. The public and private sector response has led to significant restrictions on travel, temporary business closures, quarantines, stock market volatility, and a general reduction in consumer and commercial activity globally. Matters outside our control have affected our business and operations and may or may continue to limit travel of employees to our business units domestically and internationally, adversely affect the health and welfare of our personnel, significantly reduce the demand for our products, hinder our ability to provide goods and services to customers, cause disruptions in our supply chains, adversely affect our business partners or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 and in our Annual Report on Form 10-K for the year ended December 31, 2020. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.
CONTACT:
INVESTORS
Jonathan Lock
SVP, Chief Development Officer and Investor Relations
+1.302.773.2263
investor@chemours.com
NEWS MEDIA
Cassie Olszewski
Media Relations and Financial Communications Manager
+1.302.219.7140
media@chemours.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/chemours-adds-glyclean-d-to-its-world-class-glycolic-acid-product-portfolio-301425004.html
SOURCE The Chemours Company
FAQ
What is Glyclean™ D launched by Chemours?
When was Glyclean™ D announced?
What are the benefits of Glyclean™ D compared to traditional disinfectants?
In which regions is Glyclean™ D available?
What is the stock symbol for Chemours?
